Published in Neuroscience on February 09, 2007
mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science (2010) 10.97
The behavioral pharmacology of hallucinogens. Biochem Pharmacol (2007) 1.35
Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors. Cereb Cortex (2008) 0.98
Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability. J Neurosci (2010) 0.96
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res (2014) 0.95
Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans. Psychopharmacology (Berl) (2007) 0.92
Modeling "psychosis" in vitro by inducing disordered neuronal network activity in cortical brain slices. Psychopharmacology (Berl) (2009) 0.90
Anxiety in liver X receptor β knockout female mice with loss of glutamic acid decarboxylase in ventromedial prefrontal cortex. Proc Natl Acad Sci U S A (2012) 0.89
Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement. Psychopharmacology (Berl) (2013) 0.88
Serotonin receptor expression in human prefrontal cortex: balancing excitation and inhibition across postnatal development. PLoS One (2011) 0.86
MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain. Neurotoxicology (2010) 0.85
Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex. Neuroscience (2015) 0.84
Inhibitory contribution to suprathreshold corticostriatal responses: an experimental and modeling study. Cell Mol Neurobiol (2009) 0.82
Contribution of different classes of glutamate receptors in the corticostriatal polysynaptic responses from striatal direct and indirect projection neurons. BMC Neurosci (2013) 0.79
Tonic neuromodulation of the inspiratory rhythm generator. Front Physiol (2012) 0.77
Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci (2005) 11.68
A novel slow (< 1 Hz) oscillation of neocortical neurons in vivo: depolarizing and hyperpolarizing components. J Neurosci (1993) 7.89
Neuronal avalanches in neocortical circuits. J Neurosci (2003) 7.73
Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature (1995) 5.63
Turning on and off recurrent balanced cortical activity. Nature (2003) 5.61
Neocortical network activity in vivo is generated through a dynamic balance of excitation and inhibition. J Neurosci (2006) 5.12
Interaction of sensory responses with spontaneous depolarization in layer 2/3 barrel cortex. Proc Natl Acad Sci U S A (2003) 4.57
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A (2003) 4.21
Inhibitory postsynaptic potentials carry synchronized frequency information in active cortical networks. Neuron (2005) 4.05
Spontaneous firing patterns and axonal projections of single corticostriatal neurons in the rat medial agranular cortex. J Neurophysiol (1994) 2.87
Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci (2004) 2.50
Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci (1997) 2.43
Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci (2000) 2.18
Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl) (1994) 2.09
Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc Natl Acad Sci U S A (2001) 2.03
Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci (2001) 2.01
Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol (2002) 1.87
Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential 'up' states in pyramidal neurons via D(1) dopamine receptors. Cereb Cortex (2000) 1.83
Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin. Proc Natl Acad Sci U S A (1999) 1.82
Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies. Eur Psychiatry (2005) 1.75
A neuronal glutamate transporter contributes to neurotransmitter GABA synthesis and epilepsy. J Neurosci (2002) 1.69
Persistent cortical activity: mechanisms of generation and effects on neuronal excitability. Cereb Cortex (2003) 1.60
Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J Neurosci (2004) 1.58
D1/D5 dopamine receptor activation differentially modulates rapidly inactivating and persistent sodium currents in prefrontal cortex pyramidal neurons. J Neurosci (2001) 1.54
Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J Neurophysiol (2002) 1.54
Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proc Natl Acad Sci U S A (2001) 1.51
Post-pubertal emergence of prefrontal cortical up states induced by D1-NMDA co-activation. Cereb Cortex (2004) 1.47
Thalamocortical bursts trigger recurrent activity in neocortical networks: layer 4 as a frequency-dependent gate. J Neurosci (2002) 1.44
Serotonin and hallucinogens. Neuropsychopharmacology (1999) 1.40
Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse (1997) 1.38
Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors. J Biol Chem (2004) 1.37
Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex. J Neurosci (2003) 1.31
Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse (2000) 1.31
Dopaminergic regulation of neuronal excitability through modulation of Ih in layer V entorhinal cortex. J Neurosci (2006) 1.28
D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int (2004) 1.28
D(1) dopamine receptors potentiate nmda-mediated excitability increase in layer V prefrontal cortical pyramidal neurons. Cereb Cortex (2001) 1.27
Dopamine D5 receptors of rat and human brain. Neuroscience (2000) 1.25
Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience (2003) 1.21
Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study. J Neurosci (1996) 1.18
Dopamine increases inhibition in the monkey dorsolateral prefrontal cortex through cell type-specific modulation of interneurons. Cereb Cortex (2006) 1.17
Dopamine modulation of membrane and synaptic properties of interneurons in rat cerebral cortex. J Neurophysiol (1999) 1.07
Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuron-enriched cultures. Neurochem Int (2005) 1.06
Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol (1992) 1.05
Hallucinogen-induced UP states in the brain slice of rat prefrontal cortex: role of glutamate spillover and NR2B-NMDA receptors. Neuropsychopharmacology (2005) 1.03
Neuronal networks: flip-flops in the brain. Curr Biol (2005) 1.02
Differential roles of glial and neuronal glutamate transporters in Purkinje cell synapses. J Neurosci (2005) 1.00
Prenatal disruption of neocortical development alters prefrontal cortical neuron responses to dopamine in adult rats. Neuropsychopharmacology (2005) 0.99
The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats. Neurosci Lett (2003) 0.95
Immunohistochemical localization of the neuron-specific glutamate transporter EAAC1 (EAAT3) in rat brain and spinal cord revealed by a novel monoclonal antibody. Brain Res (1997) 0.94
Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters. Mol Pharmacol (1999) 0.94
Localization of flotillins in human brain and their accumulation with the progression of Alzheimer's disease pathology. Neurosci Lett (2000) 0.94
Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex. Brain Res (2004) 0.93
Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium currents in the prefrontal cortex. J Neurosci (2006) 0.90
Combined alpha2 and D2/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat. Int J Neuropsychopharmacol (2005) 0.89
Dopamine enhances spatiotemporal spread of activity in rat prefrontal cortex. J Neurophysiol (2004) 0.87
Adenosine preferentially suppresses serotonin2A receptor-enhanced excitatory postsynaptic currents in layer V neurons of the rat medial prefrontal cortex. Neuroscience (2001) 0.86
D1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex. Brain Res (2000) 0.86
D1-receptor antagonists: comparison of [3H]SCH39166 to [3H]SCH23390. J Chem Neuroanat (1992) 0.85
Dopamine D1 and D4 receptor subtypes differentially modulate recurrent excitatory synapses in prefrontal cortical pyramidal neurons. Neuropsychopharmacology (2006) 0.85
Transient expression of polysynaptic NMDA receptor-mediated activity during neocortical development. Neurosci Lett (1990) 0.84
Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat. Brain Res (2004) 0.83
Activation of the adenylate cyclase-dependent protein kinase pathway increases high affinity glutamate uptake into rat striatal synaptosomes. Neuropharmacology (1996) 0.79
Molecular and cellular basis of addiction. Science (1997) 3.57
Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry (1990) 3.57
Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature (1978) 2.85
Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse (1987) 2.20
Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther (1973) 2.05
The formation of synaptic junctions in developing rat brain: a quantitative electron microscopic study. Brain Res (1967) 1.90
Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res (1983) 1.82
alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science (1982) 1.65
Carbon dioxide regulates the tonic activity of locus coeruleus neurons by modulating a proton- and polyamine-sensitive inward rectifier potassium current. Neuroscience (1997) 1.63
Physiological evidence for habenula as major link between forebrain and midbrain raphe. Science (1977) 1.61
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat New Biol (1973) 1.61
Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther (2000) 1.58
Fine structural and cytochemical analysis of the staining of synaptic junctions with phosphotungstic acid. J Ultrastruct Res (1968) 1.56
Effects of amphetamine on single cell activity in a catecholamine nucleus, the locus coeruleus. Nature (1971) 1.55
Selective reduction of tryptophan hydroxylase activity in rat forebrain after midbrain raphe lesions. Brain Res (1971) 1.54
Serotonin receptors in the brain. Fed Proc (1977) 1.46
Choline: selective accumulation by central cholinergic neurons. J Neurochem (1973) 1.45
Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry (1996) 1.41
Serotonergic facilitation of facial motoneuron excitation. Brain Res (1979) 1.41
Modulation of a transient outward current in serotonergic neurones by alpha 1-adrenoceptors. Nature (1985) 1.40
Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res (1975) 1.40
Dopamine"autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies. Naunyn Schmiedebergs Arch Pharmacol (1977) 1.39
CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci (1997) 1.38
Cytochemistry of synapses: selective staining for electron microscopy. Science (1966) 1.38
Intracellular studies showing modulation of facial motoneurone excitability by serotonin. Nature (1980) 1.36
Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci (1990) 1.34
Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra. Brain Res (1978) 1.32
Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J Comp Neurol (1978) 1.31
Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur J Pharmacol (1977) 1.31
Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology (1980) 1.27
5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol (1999) 1.26
Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: pharmacological differentiation using microiontophoretic techniques. Life Sci (1976) 1.25
Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur J Pharmacol (1974) 1.21
Action of psychotogenic drugs on single midbrain raphe neurons. J Pharmacol Exp Ther (1970) 1.20
Lysergic acid diethylamide and serotonin: direct actions on serotonin-containing neurons in rat brain. Life Sci I (1972) 1.20
Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology (1988) 1.19
5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci (1997) 1.19
Pertussis toxin blocks the outward currents evoked by opiate and alpha 2-agonists in locus coeruleus neurons. Brain Res (1986) 1.18
Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the alpha-antagonist piperoxane. Brain Res (1976) 1.17
Opiate- and alpha 2-adrenoceptor-induced hyperpolarizations of locus ceruleus neurons in brain slices: reversal by cyclic adenosine 3':5'-monophosphate analogues. J Neurosci (1985) 1.17
Intracellular identification of central noradrenergic and serotonergic neurons by a new double labeling procedure. J Neurosci (1982) 1.16
Hyperpolarization of serotonergic neurons by serotonin and LSD: studies in brain slices showing increased K+ conductance. Brain Res (1984) 1.16
Prazosin selectively antagonizes neuronal responses mediated by alpha1-adrenoceptors in brain. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.16
Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe. Science (1968) 1.16
Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain Res (1977) 1.16
The role of Kv1.2-containing potassium channels in serotonin-induced glutamate release from thalamocortical terminals in rat frontal cortex. J Neurosci (2001) 1.16
Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry (1994) 1.16
Noradrenergic innervation of serotonergic neurons in the dorsal raphe: demonstration by electron microscopic autoradiography. Brain Res (1981) 1.15
The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatry Clin Neurosci (1997) 1.13
Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus. Brain Res Bull (1994) 1.12
Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Res (1997) 1.10
Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique. Brain Res (1977) 1.09
Pacemaker potentials of serotonergic dorsal raphe neurons: contribution of a low-threshold Ca2+ conductance. Synapse (1987) 1.08
Caveat emptor: researcher beware. Neuropsychopharmacology (1999) 1.07
Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons. Eur J Pharmacol (1987) 1.07
Molecular control of locus coeruleus neurotransmission. Biol Psychiatry (1999) 1.07
Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science (1978) 1.07
Effect of antipsychotic drugs on the firing of dorsal raphe cells. II. Reversal by picrotoxin. Eur J Pharmacol (1976) 1.06
Gamma-hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy. J Pharmacol Exp Ther (1970) 1.06
Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: association with an up-regulation of the cyclic AMP pathway. Neuroscience (2000) 1.05
Serotonin induces EPSCs preferentially in layer V pyramidal neurons of the frontal cortex in the rat. Cereb Cortex (2000) 1.05
Activation of locus coeruleus neurons by peripheral stimuli: modulation by a collateral inhibitory mechanism. Life Sci (1978) 1.05
Modulation of lateral geniculate neurone excitability by noradrenaline microiontophoresis or locus coeruleus stimulation. Nature (1980) 1.04
(-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur J Pharmacol (1986) 1.03
Pertussis toxin blocks autoreceptor-mediated inhibition of dopaminergic neurons in rat substantia nigra. Brain Res (1987) 1.02
Increased turnover of norepinephrine in the rat cerebral cortex during stress: role of the locus coeruleus. Neuropharmacology (1973) 1.02
LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. J Pharmacol Exp Ther (1996) 1.02
Serotonin: release in the forebrain by stimulation of midbrain raphé. Science (1967) 1.01
Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. J Pharmacol Exp Ther (1973) 1.01
Evidence for G protein mediation of serotonin- and GABAB-induced hyperpolarization of rat dorsal raphe neurons. Brain Res (1988) 1.01
Electron-microscopic localization of tritiated norepinephrine in rat brain: effect of drugs. J Pharmacol Exp Ther (1967) 1.00
Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur J Pharmacol (1992) 1.00
Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis. Brain Res (1989) 0.99
Electron-microscopic autoradiography of rat hypothalamus after intraventricular h3-norepinephrine. Science (1966) 0.99
The cholinergic pharmacology of hippocampal pyramidal cells: a microiontophoretic study. Neuropharmacology (1976) 0.98
Raphe origin of serotonergic nerves terminating in the cerebral ventricles. Brain Res (1975) 0.98
An electron microscopic analysis of large granular synaptic vesicles of the brain in relation to monoamine content. J Pharmacol Exp Ther (1968) 0.98
Central noradrenergic neurons: a locus for the functional interplay between alpha-2 adrenoceptors and opiate receptors. J Clin Psychiatry (1982) 0.96
Serotonin excitation of facial motoneurons: receptor subtype characterization. Synapse (1990) 0.96
Comparison of effects of LSD and amphetamine on midbrain raphe units. Nature (1969) 0.96
Serotonergic and non-serotonergic neurons of the dorsal raphe: reciprocal changes in firing induced by peripheral nerve stimulation. Brain Res (1978) 0.95
Opiates suppress a resting sodium-dependent inward current and activate an outward potassium current in locus coeruleus neurons. J Neurosci (1993) 0.94
Neural release of brain serotonin and body temperature. Nature (1967) 0.93
Peripheral serotonin antagonists: failure to antagonize serotonin in brain areas receiving a prominent serotonergic input. J Neural Transm (1974) 0.93
A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropsychopharmacology (1996) 0.93
Intracellular recordings from serotonergic dorsal raphe neurons: pacemaker potentials and the effect of LSD. Brain Res (1982) 0.93
Relative potencies of alpha-1 and alpha-2 antagonists in the locus ceruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J Pharmacol Exp Ther (1982) 0.93
Locus coeruleus activity in vitro: intrinsic regulation by a calcium-dependent potassium conductance but not alpha 2-adrenoceptors. J Neurosci (1984) 0.92
Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons. Eur J Pharmacol (1984) 0.92
Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving a serotonergic input. J Pharmacol Exp Ther (1974) 0.92
Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res (1993) 0.91
Inhibiton of neurons in the amygdala by dorsal raphe stimulation: mediation through a direct serotonergic pathway. Brain Res (1977) 0.91
Neuronally activated metabolism of brain serotonin: effect of lithium. Life Sci (1970) 0.91
Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia. Schizophr Res (1991) 0.91
Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity. Eur J Pharmacol (1986) 0.91
Serotonin-induced depolarization of rat facial motoneurons in vivo: comparison with amino acid transmitters. Brain Res (1982) 0.90
Activation of lateral geniculate neurons by locus coeruleus or dorsal noradrenergic bundle stimulation: selective blockade by the alpha 1-adrenoceptor antagonist prazosin. Brain Res (1982) 0.90
Opiate and alpha 2-adrenoceptor responses of rat amygdaloid neurons: co-localization and interactions during withdrawal. J Neurosci (1985) 0.90
Dual control of dorsal raphe serotonergic neurons by GABA(B) receptors. Electrophysiological and microdialysis studies. Synapse (2000) 0.90
Antidromically identified serotonergic neurons in the rat midbrain raphe: evidence for collateral inhibition. Brain Res (1977) 0.90